Quantitative analysis of focal masses at MR imaging: A plea for standardization

Radiology

Volumn 231, Issue 3, 2004, Pages 737-744

  Pijl, Milan E J ^a   Doornbos, Joost ^a   Wasser, Martin N J M ^a   Van Houwelingen, Hans C ^a   Tollenaar, Rob A E M ^a   Bloem, Johan L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Data analysis; Liver neoplasms; Liver neoplasms, metastases; Liver neoplasms, MR; Magnetic resonance (MR), tissue characterization

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; LIVER METASTASIS; LIVER PARENCHYMA; MALE; MATHEMATICAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL NOISE RATIO; STANDARDIZATION; TUMOR DIAGNOSIS;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REFERENCE STANDARDS;

EID: 2442711552     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2313030173     Document Type: Article

References (42)

1. Paley MR, Mergo PJ, Torres GM, Ros PR. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging. AJR Am J Roentgenol 2000; 175:159-163.
2. Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB. Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology 2000; 214:483-490.
3. Ward J, Guthrie JA, Scott DJ, et al. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 2000; 216:154-162.
4. Scott J, Ward J, Guthrie JA, Wilson D, Robinson PJ. MRI of liver: a comparison of CNR enhancement using high dose and low dose ferumoxide infusion in patients with colorectal liver metastases. Magn Reson Imaging 2000; 18:297-303.
5. Ba-Ssalamah A, Heinz-Peer G, Schima W, et al. Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP. J Magn Reson Imaging 2000; 11:665-672.
6. Aschoff AJ, Merkle EM, Wong V, et al. How does alteration of hepatic blood flow affect liver perfusion and radiofrequency-induced thermal lesion size in rabbit liver? J Magn Reson Imaging 2001; 13:57-63.
7. Braga HJ, Imam K, Bluemke DA. MR imaging of intrahepatic cholangiocarcinoma: use of ferumoxides for lesion localization and extension. AJR Am J Roentgenol 2001; 177:111-114.
8. Wolff SD, Balaban RS. Assessing contrast on MR images. Radiology 1997; 202:25-29.
9. Rothbarth J, Pijl MEJ, Vahrmeijer AL, et al. Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver. Br J Surg 2003; 90:1391-1397.
10. Cosgrove DO. Malignant liver disease. In: Meire HB, Cosgrove DO, Dewbury KC, Farrant P, eds. Abdominal and general ultrasound. 2nd ed. London, England: Churchill Livingstone, 2001; 209-234.
11. Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J Surg 1982; 6:3-9.
12. Itai Y, Ohtomo K, Furui S, Minami M, Yoshikawa K, Yashiro N. Lobar intensity differences of the liver on MR imaging. J Comput Assist Tomogr 1986; 10:236-241.
13. Kaufman L, Kramer DM, Crooks LE, Ortendahl DA. Measuring signal-to-noise ratios in MR imaging. Radiology 1989; 173:265-267.
14. Hendrick RE. Measurement of signal, noise, and SNR in MR images. In: Hendrick RE, Russ PD, Simon JH, eds. MRI: principles and artifacts. New York: Raven, 1993; 2-6.
15. Mori K, Yoshioka H, Itai Y, et al. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. AJR Am J Roentgenol 2000; 175:1659-1664.
16. Runge VM, Kenney CM. Phase II double-blind, dose-ranging clinical evaluation of gadobenate dimeglumine in focal liver lesions: with analysis of liver and kidney signal change on early and delayed imaging. J Magn Reson Imaging 2000; 11:655-664.
17. Aschoff AJ, Rafie N, Jesberger JA, Duerk JL, Lewin JS. Thermal lesion conspicuity following interstitial radiofrequency thermal tumor ablation in humans: a comparison of STIR, turbo spin-echo T2-weighted, and contrast-enhanced T1-weighted MR images at 0.2 T. J Magn Reson Imaging 2000; 12:584-589.
18. Jeong YY, Mitchell DG, Holland GA. Liver lesion conspicuity: T2-weighted breathhold fast spin-echo MR imaging before and after gadolinium enhancement-initial experience. Radiology 2001; 219:455-460.
19. Materne R, Horsmans Y, Jamart J, Smith AM, Gigot JF, Van Beers BE. Gadolinium-enhanced arterial-phase MR imaging of hypervascular liver tumors: comparison between tailored and fixed scanning delays in the same patients. J Magn Reson Imaging 2000; 11:244-249.
20. Nakayama M, Yamashita Y, Mitsuzaki K, et al. Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging. J Magn Reson Imaging 2000; 11:647-654.
21. Matsuo M, Kanematsu M, Murakami T, et al. T2-weighted MR imaging for focal hepatic lesion detection: supplementary value of breath-hold imaging with half-Fourier single-shot fast spin-echo and multishot spin-echo echoplanar sequences. J Magn Reson Imaging 2000; 12:444-452.
22. Kanematsu M, Itoh K, Matsuo M, et al. Malignant hepatic tumor detection with ferumoxides-enhanced MR imaging with a 1.5-T system: comparison of four imaging pulse sequences. J Magn Reson Imaging 2001; 13:249-257.
23. Pauleit D, Textor J, Bachmann R, et al. Improving the detectability of focal liver lesions on T2-weighted MR images: ultrafast breath-hold or respiratory-triggered thin-section MRI? J Magn Reson Imaging 2001; 14:128-133.
24. Katayama M, Masui T, Kobayashi S, et al. Fat-suppressed T2-weighted MRI of the liver: comparison of respiratory-triggered fast spin-echo, breath-hold single-shot fast spin-echo, and breath-hold fast-recovery fast spin-echo sequences. J Magn Reson Imaging 2001; 14:439-449.
25. Hori M, Murakami T, Kim T, et al. Single breath-hold T2-weighted MR imaging of the liver: value of single-shot fast spinecho and multishot spin-echo echoplanar imaging. AJR Am J Roentgenol 2000; 174:1423-1431.
26. Raman SS, Lu DS, Chen SC, Sayre J, Eilber F, Economou J. Hepatic MR imaging using ferumoxides: prospective evaluation with surgical and intraoperative sonographic confirmation in 25 cases. AJR Am J Roentgenol 2001; 177:807-812.
27. Lim JH, Choi D, Cho SK, et al. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 2001; 220:669-676.
28. Rydberg JN, Tervonen OA, Rydberg DB, Lomas DJ, Ehman RL, Riederer SJ. Dualecho breathhold T(2)-weighted fast spin echo MR imaging of liver lesions. Magn Reson Imaging 2000; 18:117-124.
29. Pawluk RS, Borrello JA, Brown JJ, McFarland EG, Mirowitz SA, Tsao LY. A prospective assessment of breath-hold fast spin echo and inversion recovery fast spin echo techniques for detection and characterization of focal hepatic lesions. Magn Reson Imaging 2000; 18:543-551.
30. Papanikolaou N, Moulopoulos LA, Gouliamos A, Ispanopoulou S, Vlahos L. Comparison of dual spin echo echo planar imaging (SE_EPI), turbo spin echo with fat suppression and conventional dual spin echo sequences for T(2)-weighted MR imaging of focal liver lesions. Magn Reson Imaging 2000; 18:715-719.
31. Yoshiokaa H, Itai Y, Saida Y, Mori K, Mori H, Okumura T. Superparamagnetic iron oxide-enhanced MR imaging for early and late radiation-induced hepatic injuries. Magn Reson Imaging 2000; 18:1079-1088.
32. Romijn MG, Stoker J, van Eijck CH, van Muiswinkel JM, Torres CG, Lameris JS. MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer. J Magn Reson Imaging 2000; 12:261-268.
33. Masui T, Katayama M, Kobayashi S, Sakahara H, Ito T, Nozaki A. T2-weighted MRI of the female pelvis: comparison of breath-hold fast-recovery fast spin-echo and nonbreath-hold fast spin-echo sequences. J Magn Reson Imaging 2001; 13:930-937.
34. Seki H, Takano T, Sakai K. Value of dynamic MR imaging in assessing endometrial carcinoma involvement of the cervix. AJR Am J Roentgenol 2000; 175:171-176.
35. Scialpi M, Di Maggio A, Midiri M, Loperfido A, Angelelli G, Rotondo A. Small renal masses: assessment of lesion characterization and vascularity on dynamic contrast-enhanced MR imaging with fat suppression. AJR Am J Roentgenol 2000; 175:751-757.
36. Aschoff AJ, Sulman A, Martinez M, et al. Perfusion-modulated MR imaging-guided radiofrequency ablation of the kidney in a porcine model. AJR Am J Roentgenol 2001; 177:151-158.
37. Essig M, Deimling M, Hawighorst H, Debus J, van Kaick G. Assessment of cerebral gliomas by a new dark fluid sequence, high intensity REduction (HIRE): a preliminary study. J Magn Reson Imaging 2000; 11:506-517.
38. Patola WB, Coulter BA, Chipperfield PM, Lingawi SS. A comparison of conventional spin-echo and fast spin-echo in the detection of multiple sclerosis. J Magn Reson Imaging 2001; 13:657-667.
39. Ba-Ssalamah A, Schick S, Herneth AM, et al. Preoperative fast MRI of brain tumors using three-dimensional segmented echo planar imaging compared to three-dimensional gradient echo technique. Magn Reson Imaging 2000; 18:635-640.
40. Ba-Ssalamaha A, Schick S, Heimberger K, et al. Ultrafast magnetic resonance imaging of the brain. Magn Reson Imaging 2000; 18:237-243.
41. Essig M, Schoenberg SO, Debus J, van Kaick G. Disappearance of tumor contrast on contrast-enhanced FLAIR imaging of cerebral gliomas. Magn Reson Imaging 2000; 18:513-518.
42. Henkelman RM. Measurement of signal intensities in the presence of noise in MR images. Med Phys 1985; 12:232-233.